Post-Exposure Prophylaxis Decision After a Sharps Injury
A housekeeper in a 180-bed community hospital sustains a needlestick at 21:10 while emptying a sharps container that had been overfilled and forced closed. The source patient is unknown; the container held waste from a medical unit. The housekeeper has a documented hepatitis B surface antibody titer of 12 mIU/mL from a vaccine series completed five years ago and no record of a booster. She reports no prior needlestick. The occupational health clinic is closed, and the on-call infection preventionist is asked to advise the night nursing supervisor by phone. The hospital's protocol requires source testing when identifiable, baseline testing of the exposed worker, and risk assessment within two hours of exposure. The worker is anxious and asks whether she should 'just wait until morning.'
1. What immediate actions should the infection preventionist direct, and which cannot wait until morning?
Read the worked answer
Several elements are time-sensitive and cannot be deferred:
- Wound care now - wash the site with soap and water (no scrubbing, no caustic agents, no squeezing).
- Baseline serology and liver enzymes drawn tonight: HIV, HCV antibody with reflex RNA, and HBsAg/anti-HBs/anti-HBc. Baseline testing is required to interpret later seroconversion.
- HBV status is the urgent driver. An anti-HBs of 12 mIU/mL is below the protective threshold of 10 mIU/mL only marginally - it is technically above 10 but is a low, waning titer with no booster on record. Because the source is unknown, the safest reading is that protection is not assured. Give HBV immune globulin and start the hepatitis B vaccine series (or a booster dose per protocol) tonight; do not wait for source results that will never come.
- HIV PEP decision tonight. Unknown-source exposure from a medical-unit container is a low but non-zero risk. Current guidance supports offering PEP after risk assessment; the 2-hour window matters because PEP is most effective when started early and is generally not recommended beyond 72 hours. The IP should facilitate a rapid risk discussion and, if PEP is indicated, arrange the first dose from the night pharmacy rather than deferring.
- HCV has no post-exposure prophylaxis; the action is baseline testing plus follow-up RNA testing at an appropriate interval.
- Document and report the overfilled container as an incident and initiate a container-replacement audit - the exposure is a systems failure, not just an individual event.
2. The nursing supervisor says, 'The container was from a medical floor, so the risk is basically zero - can we skip PEP?' How should the IP respond?
Read the worked answer
The IP should push back on the framing while acknowledging the low risk:
- 'Basically zero' is not zero. Medical-unit waste can include blood from patients with unrecognized HIV or HCV, and the source is unknown, so no individual risk stratification is possible. Unknown-source exposures are managed conservatively.
- The decision is a shared clinical judgement, not a unilateral nursing call. The IP's role is to present the risk estimate, the benefit of PEP, and the 72-hour window, then ensure a qualified clinician makes and documents the decision. If the worker wants PEP and a clinician agrees it is reasonable, start it tonight.
- The cost of waiting is asymmetric. Starting PEP that is later discontinued carries far less harm than missing the window. If the clinician decides against PEP, document the rationale and the worker's understanding, and still complete baseline and follow-up testing.
- Do not let the container's location substitute for source assessment. The correct response to an unknown source is to follow the protocol's conservative branch, not to invent a risk category.
- Close the loop on the systems issue - overfilled containers are a recurring cause of needlesticks and should trigger a unit-level audit and staff education.
3. Outline the follow-up testing schedule and the surveillance obligations the IP owes after tonight.
Read the worked answer
Follow-up should be structured and documented:
- HIV: repeat testing at approximately 6 weeks, 3 months, and 6 months after exposure (extend to 12 months if PEP was taken, per local protocol).
- HCV: HCV RNA or antibody testing at baseline and at approximately 4–6 months; some protocols add an earlier RNA at 4–6 weeks. No prophylaxis exists, so early detection for treatment is the goal.
- HBV: if immune globulin and vaccine were given, confirm response with anti-HBs testing 1–2 months after the final dose; if the worker was already a vaccine responder, document the booster and serology.
- Symptom monitoring: instruct the worker to report fever, jaundice, rash, or flu-like illness promptly.
- Confidentiality: results are managed through occupational health, not the unit.
- Surveillance and prevention: log the exposure in the sharps injury surveillance system, review container-fill practices on the unit, verify that replacement containers are available and that staff know not to force-close overfilled units, and report to the safety committee. The IP should also confirm the worker's vaccination records are reconciled so a future exposure is not complicated by an unknown titer.